Latest News & Features
Asia
Pfizer has revealed that it will invest approximately $350 million to develop a Global Biotechnology Center in China. 5 July 2016
Americas
Pharmaceutical company Teva and US-based Antares Pharma have launched a generic version of Imitrex, which is used to treat migraines. 4 July 2016
Americas
Law firm McDermott Will & Emery has hired Edward Gordon as a partner in the firm’s intellectual property practice in Boston. 4 July 2016
Americas
Genzyme has sued Zydus Pharmaceuticals in a lawsuit that claims that the company has infringed two of its patents. 1 July 2016
Americas
NuVasive, a medical device company focused on spinal surgery, has agreed to settle its patent dispute with Medtronic. 1 July 2016
Americas
AstraZeneca has sued the US Food and Drug Administration, asking a court to prevent the FDA from approving any generic version of Crestor, which is due to expire on July 8 this year. 30 June 2016
Americas
The Biotechnology Innovation Organisation has welcomed Hillary Clinton’s plans to improve the US’s patent system. 30 June 2016
Big Pharma
The UK’s vote to leave the EU has triggered an immediate need for innovative life sciences companies to evaluate the impact on their patent strategies, argues Laetitia Benard of Allen & Overy. 30 June 2016
Biotechnology
Is it time for healthcare regulators and patent offices to limit the strategies used by existing biologic manufacturers and allow new suppliers to reach some of the world’s most lucrative healthcare systems? Elizabeth Ward of Virtuoso Legal investigates. 30 June 2016
Americas
BTG International and Janssen have sued Glenmark Pharmaceuticals claiming it has infringed a patent covering the Zytiga drug. 29 June 2016